Loading provider…
Loading provider…
Pulmonary Disease Physician in Long Beach, CA
NPI: 1386904720Primary Practice Location
ST MARY MEDICAL CENTER
1050 Linden Ave, Long Beach, CA
Primary Employer
Fady a Youssef MD Inc
memorialcare.org
HQ Phone
Get Dr. Fady's Phone Numberphone_androidMobile
Get Dr. Fady's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2014 - 2027

American Board of Internal Medicine
Internal Medicine

American Board of Internal Medicine
Critical Care Medicine

American Board of Internal Medicine
Pulmonary Disease
University of California (Irvine)
Fellowship • Pulmonary Disease and Critical Care Medicine
2015 - 2019
Residency • Internal Medicine
2012 - 2015
UC Irvine School of Medicine
medschool.uci.edu
Medical School
Until 2012
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99291Critical care delivery critically ill or injured patient, first 30-74 minutes | 119 | 282 |
| 2 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 103 | 174 |
| 3 | 99233Subsequent hospital inpatient care, typically 35 minutes per day | 44 | 70 |
Authors: Nuala Meyer, Laura Esserman, Kashif Khan, Kevin Gibbs, Paul Berger, Derek Russell, Daniel Files, Purnema Madahar, Melissa Coleman, Karl Thomas, Neil Aggarwal, Julie Lang, Jeremy Beitler, Michael Matthay, Carolyn Calfee, Ellen Burnham, Farjad Sarafian
Journal: BMJ Open
Publication Date: 2022-06-06
Analgesia-first sedation in critically ill adults: A U.S. pilot, randomized controlled trial.
Authors: Ramy Sidhom, Maged Tanios, James Leo, Fady Youssef, Arunpal Sehgal, Scott Epstein, Huan Nguyen
Journal: J Crit Care
Publication Date: 2019-06-12
A 51-Year-Old Woman With Rapidly Progressive Dyspnea.
Authors: Savita Ries, Ken Stern
Publication Date: 2021-04-06
Lead Sponsor: CalciMedica, Inc.
Intervention / Treatment: DRUG: Placebo, DRUG: Auxora
Lead Sponsor: CalciMedica, Inc.
Intervention / Treatment: OTHER: Placebo, DRUG: CM-4620 Injectable Emulsion or CM-4620-IE
Lead Sponsor: Incyte Corporation
Intervention / Treatment: DRUG: Placebo, DRUG: Ruxolitinib